GGrantIndex
← Search

ABILITY OF FENOFIBRATE AND ROSIGLITAZONE TO DECREASE CARDIOVASCULAR DISEASE

$88,066M01FY2006RRNIH

Stanford University, Stanford CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →